Reversal of Rivaroxaban-Induced Alterations on Hemostasis by Different Coagulation Factor Concentrates

Circulation Journal - Japan
doi 10.1253/circj.cj-14-0909
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Determination of Rivaroxaban by Different Factor Xa Specific Chromogenic Substrate Assays: Reduction of Interassay Variability

Journal of Thrombosis and Thrombolysis
Cardiovascular MedicineHematologyCardiology
2011English

Therapeutic Plasma Exchange for Urgent Rivaroxaban Reversal

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2018English

Hemostasis Alterations in Metabolic Syndrome (Review)

International Journal of Molecular Medicine
MedicineGenetics
2006English

Fibrinogen Depletion After Plasma-Dilution: Impairment of Proteolytic Resistance and Reversal via Clotting Factor Concentrates

Thrombosis and Haemostasis
Hematology
2014English

Clotting Factor Concentrates.

BMJ
1972English

First-Line Therapy With Coagulation Factor Concentrates Combined With Point-Of-Care Coagulation Testing Is Associated With Decreased Allogeneic Blood Transfusion in Cardiovascular Surgery

Anesthesiology
AnesthesiologyPain Medicine
2011English

Differential Calcium Alterations in Animal Models of Neurodegenerative Disease: Reversal by FK506

Neuroscience
Neuroscience
2015English

Growth Factor-Mediated Reversal of Senescent Dysfunction of Ischemia-Induced Cardioprotection

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2006English

Activated Plasma Coagulation Β-Factor XII-induced Vasoconstriction in Rats

Clinical Science
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy